CAMBRIDGE, Mass., Oct. 29, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conferencecall on Monday, November 5, 2018, at 4:30 p.m. ET to review its third quarter 2018 financial results and provide an update on the company.
A live webcast of the conference call can
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Stephanie Ascher, Stern Investor Relations, Inc.212-362-1200 or Stephanie@sternir.com
View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-third-quarter-2018-financial-results-conference-call-and-webcast-300739145.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!